Recent News

Kaligia Biosciences completes calibration testing for the latest RBA device

Kaligia Biosciences’ Reagent-Free Whole Blood Hemoglobin Analyzer has been tested in conjunction with our collaborators at AdventHealth & HEP.

We are currently in the submission process with the FDA for 510(k) approval.

Kaligia Biosciences

On the forefront of healthcare technology

Revolutionary high-speed point of care devices.

Our Basic Process

Quantifiable Results, Unprecedented Speed.

Kaligia Biosciences is tapping into the power of emerging technologies and creative problem-solving to innovate a new breed of biosensors. These devices, which produce quantifiable results with unprecedented speed and accuracy, align with Kaligia Biosciences’ mission to redefine medical diagnosis and transform healthcare delivery from reactive to proactive.


Sample fluid collected from patient.


High-intensity laser and detector records unique light signatures.

Machine Learning

Proprietary algorithms analyze the light signatures.

Rapid Results

Results delivered almost instantaneously.

Kaligia Biosciences

Our Product

Rapid Biofluid Analyzer (RBA)

Learn More
Medical Partnerships

Solving Complex Problems Together

Kaligia Biosciences has begun clinical trials in partnership with numerous hospitals in the Tampa Bay area.

News and Media

Our Latest Posts


Company News

Tampa Bay Company Develops Coronavirus Saliva Test

September 28, 2020
LARGO, Fla. — A Tampa Bay company is awaiting FDA approval for a COVID-19 testing…
Product Information

Kaligia Biosciences’ COVID-19 Rapid Biofluid Analyzer 2 Featured on ABC Action News

June 10, 2020
The co-founder and CEO of Kaligia Biosciences, Fazal Fazlin, spoke with ABC News regarding the…
Research & Partnerships

Kaligia Biosciences’ COVID-19 Clinical Trials Begin – Tampa Bay Times

May 22, 2020
Kaligia Biosciences has begun clinical tests with its Rapid Biofluid Analyzer utilizing saliva to detect…